Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.150
-0.090 (-7.26%)
At close: May 9, 2025, 4:00 PM
1.170
+0.020 (1.74%)
After-hours: May 9, 2025, 7:57 PM EDT
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $73.88 million as of May 9, 2025. Its market cap has decreased by -72.82% in one year.
Market Cap
73.88M
Enterprise Value
7.66M
1-Year Change
-72.82%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $73.88M, a decrease of -79.27%. That is a compound annual growth rate of -27.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 79.66M | -55.23% |
| Dec 31, 2024 | 177.95M | -32.37% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.75B |
| Johnson & Johnson | 378.74B |
| UnitedHealth Group | 353.21B |
| AbbVie | 333.06B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 220.92B |
| AstraZeneca | 217.30B |